Month: February 2017
-
Cancer Drug Shown to Improve Survival Time in Dogs
A drug to treat a deadly cancer in dogs was shown in a clinical trial to extend the survival time of canine patients by 6 months or more, with potential applications in humans.
-
Ford Investing $1B in Artificial Intelligence Start-Up
Ford Motor Company is investing $1 billion in a start-up enterprise that applies artificial intelligence to the operation and management of autonomous vehicles.
-
Biotechs License Solid Tumor Therapy in $2.1B Deal
Biotechnology enterprise Immunomedics Inc. is licensing its enhanced antibody-based treatment for solid tumor cancers to Seattle Genetics, a developer of similar cancer drugs.
-
Low-Dose Multidrug Shown Effective in Hypertension Trial
A small-scale clinical trial shows a combination of four current drugs to treat hypertension, or high blood pressure, formulated in low doses, reduces blood pressure to normal levels in four weeks.
-
Gates Grant Funding Malaria Control Test Products
Two universities in the U.K. are developing testing protocols for a new generation of technologies coming to market to prevent mosquitoes from spreading diseases.
-
System Slashes Time to Detect Bacteria in Blood
A biomedical engineering lab developed a compact system that detects harmful bacteria in blood samples in less than four hours, a process that now takes days.
-
DNA Tags Speed Nanoparticle Gene Therapy Discovery
Biomedical engineers developed a technique with unique DNA identifiers that makes possible faster screening of gene therapies delivered with nanoscale particles.
-
Trial Testing Artificial Pancreas for Type 1 Diabetes
A clinical trial testing day-to-day use of a smartphone-controlled artificial pancreas for people with type 1 diabetes began enrolling participants.
-
Stomach Acid Harnessed to Power Ingestible Devices
Researchers at MIT and Harvard University designed a tiny device that in tests with animals show it can run for days powered by acids in the stomach.
-
Company, NC State Partner on Tissue Oxygen Patch
Profusa Inc. and a research center at North Carolina State University are developing a new device to monitor tissue oxygen levels in people with peripheral artery disease.